Stryker to participate in Cowen 40th Annual Health Care Conference
Get Alerts SYK Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.1%
Revenue Growth %: +10.4%
Join SI Premium – FREE
Kalamazoo, Michigan, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) ) will participate in the Cowen 40th Annual Health Care Conference on Tuesday, March 3, 2020 at the Boston Marriott Copley Place in Boston, Massachusetts.
Katherine Owen, Vice President, Strategy & Investor Relations, will represent the Company in a presentation scheduled for 10:40 a.m. Eastern Time.
A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com. The webcast will be archived on the Investor Relations page of this site.
Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com.
Contacts
For investor inquiries please contact:Katherine Owen, Vice President, Strategy & Investor Relations at 269-385-2600 or [email protected]
For media inquiries please contact:Yin Becker, Vice President, Communications, Public Affairs and Corporate Marketing at 269-385-2600 or [email protected]
Source: Stryker CorporationSerious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA Issues Emergency Use Authorization for Drugs to Prevent and Treat New World Screwworm in Dogs and Cats
- HMP Global's Psych Congress Brings Marcus and Amber Capone, HHS Deputy General Counsel Matthew Zorn and Leading Clinicians Together for Five Days on the Future of Psychedelic Medicine
- Stryker completes first surgery using FDA-cleared Apple Vision Pro app
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share